Updates to the company's Clara healthcare platform are trying to make it easier for clinicians to train and adapt deep learning algorithms, while also making the implementation process smoother.
The company is hoping to boost the adoption of AI in medical imaging with new software development kits and deals with Ohio State University and the NIH.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.